Studies have reported that in breast cancer, the expression level of Znf704 is inversely associated with the expression level of Per2, and high levels of Znf704 are correlated with lymph node positivity, poor prognosis, and histological grading in patients with breast cancer (Yang et al., 2020). Here, PER2 is linked to breast carcinoma.